Research Progress on Copper Ion Transport Protein Family and Cisplatin Drug Resistance in Lung Cancer

YANG Tian,CHEN Tian-jun,CHEN Ming-wei

DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2012.015.017

2012-01-01

Abstract:Cisplatin is one of the most important chemotherapeutic agents,commonly used for treatment of various cancers including ovary,endometrial,lung and gastric cancer.The secondary drugresistance,however,limits the efficacy of chemotherapy and consequently compromises the prognosis of patients.Recently,there have been some important developments in the understanding of mechanisms of tumor resistance to cisplatin.One of them is concerning the association between the tumor resistance to platinum drugs and the reduced intracellular accumulation owing to impaired drug intake and enhanced outward transport.However,mechanisms for transporting platinum drugs were not known until recently studies have shown that copper transporters may be involved in the transport of platinum-based anticancer drugs.Body copper homeostasis is maintained by a group of proteins including copper transporters and chaperones.Copper transporters include copper transporter 1 and copper-transporting P-type adenosine triphosphatase.This paper will state copper ion transport protein family and cisplatin drug resistance in lung cancer.